Postoperative Hemorrhages

Also known as: Postoperative Bleeding / Operative bleeding / Perioperative Bleeding / Procedural bleeding / Postoperative Hemorrhage / Hemorrhage, Postoperative / Procedural haemorrhage / Procedural hemorrhage / Post procedural hemorrhage / Post procedural haemorrhage / Post procedural bleeding / Bleeding postoperative / Post-operative haemorrhage / Postoperative haemorrhage

DrugDrug NameDrug Description
DB13884Albutrepenonacog alfaA recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B.
DB09329Antihemophilic Factor (Recombinant), PEGylatedFor the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)...
DB00025Antihemophilic factor, human recombinantA form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency.
DB11607Efmoroctocog alfaA recombinant Factor VIII used to treat and prevent bleeding in hemophilia A.
DB11608Eftrenonacog alfaA recombinant Factor IX used to treat and prevent bleeding in hemophilia B.
DB13933Nonacog beta pegolA recombinant coagulation Factor IX derivative used to treat hemophilia B.
DrugDrug NameTargetType
DB13884Albutrepenonacog alfaCoagulation factor Xtarget
DB13884Albutrepenonacog alfaCoagulation factor VIIIenzyme
DB09329Antihemophilic Factor (Recombinant), PEGylatedvon Willebrand factortarget
DB09329Antihemophilic Factor (Recombinant), PEGylatedvon Willebrand factorcarrier
DB00025Antihemophilic factor, human recombinantCoagulation factor Xtarget
DB00025Antihemophilic factor, human recombinantPhytanoyl-CoA dioxygenase, peroxisomaltarget
DB00025Antihemophilic factor, human recombinantCoagulation factor IXtarget
DB00025Antihemophilic factor, human recombinantAsialoglycoprotein receptor 2target
DB00025Antihemophilic factor, human recombinant78 kDa glucose-regulated proteintarget
DB00025Antihemophilic factor, human recombinantCalreticulintarget
DB00025Antihemophilic factor, human recombinantCalnexintarget
DB00025Antihemophilic factor, human recombinantProtein ERGIC-53target
DB00025Antihemophilic factor, human recombinantProlow-density lipoprotein receptor-related protein 1target
DB00025Antihemophilic factor, human recombinantMultiple coagulation factor deficiency protein 2target
DB00025Antihemophilic factor, human recombinantvon Willebrand factortarget
DB00025Antihemophilic factor, human recombinantProthrombinenzyme
DB00025Antihemophilic factor, human recombinantVitamin K-dependent protein Cenzyme
DB11607Efmoroctocog alfavon Willebrand factortarget
DB13933Nonacog beta pegolCoagulation factor VIItarget
DB13933Nonacog beta pegolCoagulation factor VIIItarget
DB13933Nonacog beta pegolCoagulation factor Xtarget
DrugDrug NamePhaseStatusCount
DB11166Antithrombin Alfa1Terminated1
DB00297Bupivacaine2Terminated1
DB11242Gelatin2Completed1
DB00302Tranexamic acid2Completed1
DB06692Aprotinin3Terminated2
DB01109Heparin3Completed1
DB09106Hydroxyethyl Starch3Completed1
DB01098Rosuvastatin3Completed1
DB00302Tranexamic acid3Completed1
DB00302Tranexamic acid3Not Yet Recruiting1
DB00316Acetaminophen4Recruiting1
DB00297Bupivacaine4Completed1
DB00035Desmopressin4Completed1
DB00668Epinephrine4Completed1
DB00956Hydrocodone4Recruiting1
DB00327Hydromorphone4Recruiting1
DB09106Hydroxyethyl Starch4Completed1
DB00497Oxycodone4Recruiting1
DB09153Sodium chloride4Completed1
DB00302Tranexamic acid4Completed2
DB00302Tranexamic acid4Not Yet Recruiting1
DB00945Acetylsalicylic acidNot AvailableEnrolling by Invitation1
DB06692AprotininNot AvailableNo Longer Available1
DB00302Tranexamic acidNot AvailableUnknown Status1